Assumptions are being shaken up after the unexpected failure of the ECLIPSE trial to show an advantage for orbital ...

In this excerpt from "Too Young for Cancer," Katie Coleman describes receiving her cancer diagnosis after years of having her ...

This study found that a Western diet doubles the growth of endometriotic lesions in mice and depletes the gut microbiome's ...

Claire Turner, 43, said she didn't have changed moles or skin lesions — a rarity that occurs in about 3% of melanoma cases ...

Emrosi is expected to be available in the first quarter or early second quarter of 2025. The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) ...

Prostate cancer is the second most common cancer in men, and almost 300,000 individuals are diagnosed with it each year in ...

Several experts argue that AI-QCA is not a replacement for OCT, but could be valuable in low-resource settings.

Expert answers to patients’ questions were offered as part of the CURE® Educated Patient® Prostate Cancer Summit.

While AI-assisted colonoscopies with computer-aided detection are associated with improved adenoma detection rates, they also led to a statistically and clinically significant increase in exams that ...

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

The Food and Drug Administration has approved Emrosi ™ (minocycline hydrochloride extended-release capsules) for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

The Disrupt PAD BTK II study’s 30-day outcomes were revealed. The core lab–adjudicated, prospective, multicenter, s ...